Agios Pharmaceuticals (AGIO) Gross Profit Growth (5y) (2022 - 2025)

Agios Pharmaceuticals (AGIO) Gross Profit Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Agios Pharmaceuticals 2.20 Bn 1.46 Bn 19.43 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -16.99%
Sep 30, 2025 -19.95%
Jun 30, 2025 -21.76%
Mar 31, 2025 -38.46%
Dec 31, 2024 -23.07%
Sep 30, 2024 -20.42%
Jun 30, 2024 -22.77%
Mar 31, 2024 -24.04%
Dec 31, 2023 -25.97%
Sep 30, 2023 -14.14%
Jun 30, 2023 -32.64%
Mar 31, 2023 -10.42%
Dec 31, 2022 -16.84%
Sep 30, 2022 -23.38%